COVID-19 Vaccine Uptake Lagging in Patients With Sickle Cell Disease
By Lori Solomon HealthDay Reporter
FRIDAY, Jan. 19, 2024 -- COVID-19 immunization completion is nearly half for people with versus without sickle cell disease (SCD), according to a research letter published online Jan. 8 in JAMA Network Open.
Hannah K. Peng, from the University of Michigan in Ann Arbor, and colleagues assessed COVID-19 immunization coverage among 3,424 Michigan residents with SCD (5 years of age and older) versus 9.4 million residents without SCD.
The researchers found that COVID-19 immunization coverage for people with SCD was 33.5 percent, versus 61.3 percent for people without SCD (relative risk, 0.55). Immunization completion increased with age for people with SCD (range, 17 to 74 percent) and without SCD (range, 25 to 87 percent). By age group, relative risks were 0.68 for 5 to 11 years, 0.75 for 12 to 17 years, 0.58 for 18 to 64 years, and 0.84 for 65 years and older.
"These results are consistent with findings from health system-based studies in which fewer than half of patients with SCD completed the vaccination series," the authors write. "Misinformation and mistrust are reasons frequently associated with low COVID-19 immunization completion in the SCD community, which are also common throughout the Black population in the United States."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted January 2024
Further Support and Information on COVID-19
Read this next
Following Drop After COVID-19 Onset, Inappropriate Antibiotic Prescribing Is Up
WEDNESDAY, May 1, 2024 -- There was an initial decrease in inappropriate antibiotic prescriptions following onset of COVID-19, followed by an increase, according to a study...
Long-Term Smell, but Not Taste, Deficits Seen After COVID-19
WEDNESDAY, May 1, 2024 -- Olfactory dysfunction, especially for smell, is more common in individuals with prior COVID-19 versus individuals with no history of infection, with...
SARS-CoV-2 Vaccine Does Not Increase New-Onset Seizure Risk
TUESDAY, April 30, 2024 -- There is no risk for new-onset seizure incidence for individuals receiving a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine versus...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.